ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.

ABSTRACT: Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410.

SUBMITTER: Currier JS 

PROVIDER: S-EPMC10469341 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature